News & Events

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith  for $210 Million in Transaction to Fuel Global Expansion

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer based in Minnesota, US, from shareholders, Sawai Group Holdings Co., Ltd. (JP), and Sumitomo Corporation of Americas, for a total consideration of up to US$210 million.

CPhI Barcelona 2023

CPhI Barcelona 2023

CPhI Barcelona 2023Meet with Bora at CPhI October 24-26, 2023Fira Barcelona Booth #3D38

Bio Japan 2023

Bio Japan 2023

Bio Japan 2023Meet with Bora at Bio Japan October 11-13, 2023PACIFICO Yokohama, Japan Booth #B-19